Indeed, KRAS mutations are usually detected in colorectal, pancreatic, biliary tract, and lung carcinomas, NRAS mutation in malignant melanomas, and HRAS mutation in head and neck carcinomas (41, 42). Here, KRAS is linked to lung carcinoma.